1.Bijlsma MF, Sadanandam A, Tan P, Vermeulen L: Molecular subtypes in cancers of the gastrointestinal tract. Nature reviews Gastroenterology & hepatology 2017, 14(6):333–342.
2.Balakrishnan M, George R, Sharma A, Graham DY: Changing Trends in Stomach Cancer Throughout the World. Current gastroenterology reports 2017, 19(8):36.
3.Fitzmaurice C, Akinyemiju TF, Al Lami FH, Alam T, Alizadeh-Navaei R, Allen C, Alsharif U, Alvis-Guzman N, Amini E, Anderson BO et al: Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016: A Systematic Analysis for the Global Burden of Disease Study. JAMA oncology 2018, 4(11):1553–1568.
4.Ding K, Tan S, Huang X, Wang X, Li X, Fan R, Zhu Y, Lobie PE, Wang W, Wu Z: GSE1 predicts poor survival outcome in gastric cancer patients by SLC7A5 enhancement of tumor growth and metastasis. J Biol Chem 2018, 293(11):3949–3964.
5.Zheng J, Rutegard M, Santoni G, Wallner B, Johansson I, Sund M, Xie SH, Lagergren J: Prediabetes and diabetes in relation to risk of gastric adenocarcinoma. British journal of cancer 2019.
6.Kankeu Fonkoua L, Yee NS: Molecular Characterization of Gastric Carcinoma: Therapeutic Implications for Biomarkers and Targets. Biomedicines 2018, 6(1).
7.Cidon EU, Ellis SG, Inam Y, Adeleke S, Zarif S, Geldart T: Molecular targeted agents for gastric cancer: a step forward towards personalized therapy. Cancers 2013, 5(1):64–91.
8.Kim TJ, Lee H: Diabetic biomarkers and the risk of proximal or distal gastric cancer. 2016, 31(10):1705–1710.
9.Chi N, Epstein JA: Getting your Pax straight: Pax proteins in development and disease. Trends in genetics: TIG 2002, 18(1):41–47.
10.Mansouri A, Chowdhury K, Gruss P: Follicular cells of the thyroid gland require Pax8 gene function. Nat Genet 1998, 19(1):87–90.
11.Mittag J, Winterhager E, Bauer K, Grummer R: Congenital hypothyroid female pax8-deficient mice are infertile despite thyroid hormone replacement therapy. Endocrinology 2007, 148(2):719–725.
12.Li CG, Nyman JE, Braithwaite AW, Eccles MR: PAX8 promotes tumor cell growth by transcriptionally regulating E2F1 and stabilizing RB protein. Oncogene 2011, 30(48):4824–4834.
13.Laury AR, Hornick JL, Perets R, Krane JF, Corson J, Drapkin R, Hirsch MS: PAX8 reliably distinguishes ovarian serous tumors from malignant mesothelioma. The American journal of surgical pathology 2010, 34(5):627–635.
14.Laury AR, Perets R, Piao H, Krane JF, Barletta JA, French C, Chirieac LR, Lis R, Loda M, Hornick JL et al: A comprehensive analysis of PAX8 expression in human epithelial tumors. The American journal of surgical pathology 2011, 35(6):816–826.
15.Nonaka D, Chiriboga L, Soslow RA: Expression of pax8 as a useful marker in distinguishing ovarian carcinomas from mammary carcinomas. The American journal of surgical pathology 2008, 32(10):1566–1571.
16.Melichar HJ, Narayan K, Der SD, Hiraoka Y, Gardiol N, Jeannet G, Held W, Chambers CA, Kang J: Regulation of gammadelta versus alphabeta T lymphocyte differentiation by the transcription factor SOX13. Science (New York, NY) 2007, 315(5809):230–233.
17.Marfil V, Moya M, Pierreux CE, Castell JV, Lemaigre FP, Real FX, Bort R: Interaction between Hhex and SOX13 modulates Wnt/TCF activity. J Biol Chem 2010, 285(8):5726–5737.
18.Kido S, Hiraoka Y, Ogawa M, Sakai Y, Yoshimura Y, Aiso S: Cloning and characterization of mouse mSox13 cDNA. Gene 1998, 208(2):201–206.
19.Roose J, Korver W, de Boer R, Kuipers J, Hurenkamp J, Clevers H: The Sox–13 gene: structure, promoter characterization, and chromosomal localization. Genomics 1999, 57(2):301–305.
20.He Z, Ruan X, Liu X, Zheng J, Liu Y, Liu L, Ma J, Shao L, Wang D, Shen S et al: FUS/circ_002136/miR–138–5p/SOX13 feedback loop regulates angiogenesis in Glioma. J Exp Clin Cancer Res 2019, 38(1):65.
21.Comprehensive molecular characterization of gastric adenocarcinoma. Nature 2014, 513(7517):202–209.
22.Chen YL, Cheng KC, Lai SW, Tsai IJ, Lin CC, Sung FC, Lin CC, Chen PC: Diabetes and risk of subsequent gastric cancer: a population-based cohort study in Taiwan. Gastric cancer: official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 2013, 16(3):389–396.
23.Liu Y, Sethi NS, Hinoue T, Schneider BG, Cherniack AD, Sanchez-Vega F, Seoane JA, Farshidfar F, Bowlby R, Islam M et al: Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas. Cancer Cell 2018, 33(4):721–735.e728.
24.Duraes C, Almeida GM, Seruca R, Oliveira C, Carneiro F: Biomarkers for gastric cancer: prognostic, predictive or targets of therapy? Virchows Archiv: an international journal of pathology 2014, 464(3):367–378.
25.Posenato I, Calio A, Segala D, Sgroi S, Polara A, Brunelli M, Martignoni G: Primary seminal vesicle carcinoma. The usefulness of PAX8 immunohistochemical expression for the differential diagnosis. Human pathology 2017, 69:123–128.
26.Kar SP, Adler E, Tyrer J, Hazelett D, Anton-Culver H, Bandera EV, Beckmann MW, Berchuck A, Bogdanova N, Brinton L et al: Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci. British journal of cancer 2017, 116(4):524–535.
27.Koumarianou P, Gomez-Lopez G, Santisteban P: Pax8 controls thyroid follicular polarity through cadherin–16. 2017, 130(1):219–231.
28.Hung NA, Eiholzer RA, Kirs S, Zhou J, Ward-Hartstonge K, Wiles AK, Frampton CM, Taha A, Royds JA, Slatter TL: Telomere profiles and tumor-associated macrophages with different immune signatures affect prognosis in glioblastoma. Modern pathology: an official journal of the United States and Canadian Academy of Pathology, Inc 2016, 29(3):212–226.
29.Sarkar A, Hochedlinger K: The sox family of transcription factors: versatile regulators of stem and progenitor cell fate. Cell stem cell 2013, 12(1):15–30.
30.Kamachi Y, Kondoh H: Sox proteins: regulators of cell fate specification and differentiation. Development (Cambridge, England) 2013, 140(20):4129–4144.
31.Ivanov SV, Panaccione A, Nonaka D, Prasad ML, Boyd KL, Brown B, Guo Y, Sewell A, Yarbrough WG: Diagnostic SOX10 gene signatures in salivary adenoid cystic and breast basal-like carcinomas. British journal of cancer 2013, 109(2):444–451.
32.Huang W, Chen Z, Shang X, Tian D, Wang D, Wu K, Fan D, Xia L: Sox12, a direct target of FoxQ1, promotes hepatocellular carcinoma metastasis through up-regulating Twist1 and FGFBP1. Hepatology (Baltimore, Md) 2015, 61(6):1920–1933.
33.Duquet A, Melotti A, Mishra S, Malerba M, Seth C, Conod A, Ruiz i Altaba A: A novel genome-wide in vivo screen for metastatic suppressors in human colon cancer identifies the positive WNT-TCF pathway modulators TMED3 and SOX12. EMBO molecular medicine 2014, 6(7):882–901.